| Literature DB >> 31727101 |
M Maynar1, I Bartolomé1, J Alves2, G Barrientos2, F J Grijota3, M C Robles1, D Muñoz4.
Abstract
BACKGROUND: The aim of this survey was to determine the effects of an aerobic physical training program of six months duration on the serum and urinary concentrations of essential trace elements among middle distance runners and untrained, non-sportsmen participants.Entities:
Keywords: Blood; Essential trace elements; Exercise; Minerals; Training; Urine
Mesh:
Substances:
Year: 2019 PMID: 31727101 PMCID: PMC6857336 DOI: 10.1186/s12970-019-0322-7
Source DB: PubMed Journal: J Int Soc Sports Nutr ISSN: 1550-2783 Impact factor: 5.150
Nutritional intake of elements in controls and athletes at baseline and after the training program
| Time | ANOVA (p) | |||||
|---|---|---|---|---|---|---|
| Nutritional intake | Baseline | 6 months | Group effect | Time effect | ||
| Water (g) | CG ( | 1010.12 ± 300.22 | 1054.33 ± 320.05 | 0.15 | 0.12 | 0.38 |
| AG ( | 1044.49 ± 288.31 | 1037.15 ± 334.41 | ||||
| Energy (Kcal) | CG ( | 2847 ± 930 | 2844 ± 1000 | 0.21 | 0.34 | 0.51 |
| AG ( | 2884 ± 914 | 2535 ± 400* | ||||
| Proteins (g) | CG ( | 127.5 ± 43.3 | 128.1 ± 39.9 | 0.43 | 0.45 | 0.88 |
| AG ( | 129.7 ± 41.1 | 108.4 ± 17.6 | ||||
| Lipids (g) | CG ( | 81.15 ± 21.4 | 85.73 ± 30.50 | 0.12 | 0.18 | 0.30 |
| AG ( | 90.07 ± 32.31 | 87.62 ± 36.91 | ||||
| Carbohydrates (g) | CG ( | 360.7 ± 75.43 | 359.80 ± 72.07 | 0.34 | 0.22 | 0.45 |
| AG ( | 357.5 ± 71.39 | 332.4 ± 78.9 | ||||
| Co (0.2–0.3 mg/d) | CG ( | 0.25 ± 0.13 | 0.26 ± 0.16 | 0.32 | 0.19 | 0.55 |
| AG ( | 0.22 ± 0.14 | 0.27 ± 0.19 | ||||
| Cu (1–3 mg/d) | CG ( | 1.84 ± 0.63 | 1.81 ± 0.70 | 0.27 | 0.72 | 0.62 |
| AG ( | 1.72 ± 0.61 | 1.60 ± 0.56 | ||||
| Mn (2.5–5 mg/d) | CG ( | 3.04 ± 1.31 | 3.31 ± 1.97 | 0.32 | 0.65 | 0.87 |
| AG ( | 3.23 ± 1.41 | 3.27 ± 1.60 | ||||
| Mo (0.07–0.4 mg/d) | CG ( | 0.29 ± 0.14 | 0.27 ± 0.18 | 0.55 | 0.34 | 0.78 |
| AG ( | 0.27 ± 0.17 | 0.33 ± 0.21 | ||||
| Se (0.05–0.2 mg/d) | CG ( | 0.11 ± 0.018 | 0.09 ± 0.017 | 0.35 | 0.47 | 0.65 |
| AG ( | 0.096 ± 0.018 | 0.089 ± 0.086 | ||||
| V (10–70 μg/d) | CG ( | 15.66 ± 18.21 | 15.98 ± 17.62 | 0.41 | 0.30 | 0.61 |
| AG ( | 13.44 ± 17.19 | 31.29 ± 37.60 | ||||
| Zn (10–15 mg/d) | CG ( | 14.21 ± 5.01 | 13.89 ± 5.48 | 0.10 | 0.07 | 0.15 |
| AG ( | 11.76 ± 5.94 | 10.18 ± 2.32 | ||||
CG Control group, AG Athletes group. Values are presented as mean ± standard deviation
Ergoespirometrics results of controls and athletes at baseline and after the training program
| Time | ANOVA (p) | |||||
|---|---|---|---|---|---|---|
| Parameters | Baseline | 6 months | Group effect | Time effect | ||
| Total Weight (Kg) | CG ( | 76.94 ± 11.07 | 77.62 ± 12.14 | 0.001 | 0.2 | 0.11 |
| AG ( | 65.55 ± 7.55 | 64.73 ± 7.83 | ||||
| ∑6 Skinfold (mm) | CG ( | 62.76 ± 12.23 | 63.02 ± 13.05 | 0.001 | 0.08 | 0.13 |
| AG ( | 48.74 ± 11.17 | 46.59 ± 8.89 | ||||
| Rest HR (b/min) | CG ( | 65.12 ± 12.42 | 67.34 ± 11.71 | 0.001 | 0.13 | 0.21 |
| AG ( | 52.12 ± 12.42 | 49.87 ± 9.27 | ||||
| HR max (b/min) | CG ( | 196.33 ± 7.55 | 197.41 ± 8.01 | 0.42 | 0.51 | 0.72 |
| AG ( | 193.69 ± 7.85 | 194.30 ± 7.50 | ||||
| VO2 max (ml/kg/min) | CG ( | 45.72 ± 7.51 | 46.32 ± 8.16 | 0.001 | 0.2 | 0.31 |
| AG ( | 66.46 ± 10.12 | 67.94 ± 8.10 | ||||
| VE max (L/min) | CG ( | 98.66 ± 11.47 | 99.26 ± 16.63 | 0.001 | 0.42 | 0.25 |
| AG ( | 137.95 ± 55.34 | 129.00 ± 26.92 | ||||
CG Control group, AG Athletes group. HR Hearth rate, VO Oxygen uptake, VE Pulmonary ventilation
Values are presented as mean ± standard deviation
Serum concentrations of trace elements in controls and athletes at baseline and after the training program
| Time | ANOVA (p) | |||||
|---|---|---|---|---|---|---|
| Minerals | Baseline | 6 months | Group effect | Time effect | ||
| Co (μg/L) | CG ( | 0.81 ± 0.40 | 0.83 ± 0.51 | 0.001 | 0.52 | 0.61 |
| AG ( | 0.68 ± 0.10 | 0.67 ± 0.11 | ||||
| Cu (μg/L) | CG ( | 750.5 ± 121.5 | 760.4 ± 113.8 | 0.01 | 0.33 | 0.3 |
| AG ( | 721.5 ± 119.5 | 675.4 ± 152.2 | ||||
| Mn (μg/L) | CG ( | 1.84 ± 0.41 | 1.98 ± 1.36 | 0.01 | 0.003 | 0.04 |
| AG ( | 3.48 ± 1.50 | 1.36 ± 1.00 | ||||
| Mo (μg/L) | CG ( | 0.33 ± 0.15 | 0.34 ± 0.12 | 0.01 | 0.2 | 0.21 |
| AG ( | 0.66 ± 0.72 | 0.51 ± 0.27 | ||||
| Se (μg/L) | CG ( | 119.13 ± 14.37 | 118.43 ± 13.37 | 0.001 | 0.22 | 0.14 |
| AG ( | 98.43 ± 13.37 | 92.30 ± 13.74 | ||||
| V (μg/L) | CG ( | 0.54 ± 0.61 | 0.53 ± 0.71 | 0.2 | 0.51 | 0.52 |
| AG ( | 0.56 ± 0.50 | 0.10 ± 0.13 | ||||
| Zn (μg/L) | CG ( | 979.6 ± 114.41 | 968.3 ± 116.61 | 0.05 | 0.001 | 0.1 |
| AG ( | 658.4 ± 92.61 | 859.3 ± 125.3 | ||||
CG Control group, AG Athletes group. Values are presented as mean ± standard deviation
Urinary concentrations of elements in controls and athletes at baseline and after the training program
| Time | ANOVA (p) | |||||
|---|---|---|---|---|---|---|
| Minerals | Baseline | 6 months | Group effect | Time effect | ||
| Co (μg/g) | CG ( | 0.43 ± 0.66 | 0.44 ± 0.70 | 0.001 | 0.07 | 0.09 |
| AG ( | 0.09 ± 0.08 | 0.33 ± 0.30 | ||||
| Cu (μg/g) | CG ( | 19.66 ± 16.8 | 20.5 ± 14.5 | 0.001 | 0.001 | 0.001 |
| AG ( | 82.3 ± 47.2 | 38.19 ± 16.12 | ||||
| Mn (μg/g) | CG ( | 5.48 ± 3.59 | 4.99 ± 3.91 | 0.002 | 0.01 | 0.01 |
| AG ( | 1.33 ± 3.20 | 12.44 ± 16.98 | ||||
| Mo (μg/g) | CG ( | 34.42 ± 29.71 | 34.66 ± 30.72 | 0.51 | 0.12 | 0.13 |
| AG ( | 41.82 ± 16.64 | 38.07 ± 25.51 | ||||
| Se (μg/g) | CG ( | 23.49 ± 13.54 | 22.98 ± 13.37 | 0.001 | 0.001 | 0.001 |
| AG ( | 22.13 ± 6.09 | 18.99 ± 7.200 | ||||
| V (μg/g) | CG ( | 1.06 ± 0.78 | 0.96 ± 0.68 | 0.001 | 0.6 | 0.33 |
| AG ( | 0.93 ± 0.30 | 1.08 ± 1.47 | ||||
| Zn (μg/g) | CG ( | 261.4 ± 214.61 | 258.2 ± 207.74 | 0.28 | 0.07 | 0.08 |
| AG ( | 134.4 ± 110.1 | 264.75 ± 200.85 | ||||
CG Control group, AG Athletes group. Values are presented as mean ± standard deviation